During the past decade, Engineering Research Building conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Engineering Research Building" are "Cardiovascular Diseases" (2 trials), "Cardiovascular Risk Factor" (2 trials), "Vasoconstriction" (1 trials) and "Vasodilation" (1 trials). Many other conditions were trialed in "Engineering Research Building" in a lesser frequency.

Most popular intervention types in "Engineering Research Building" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Allopurinol" (2 trials), "Apocynin" (2 trials), "Acetyl-ß-methylcholine chloride" (1 trials), "BH4" (1 trials) and "Control (Lactated Ringer's)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Engineering Research Building" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Engineering Research Building". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Engineering Research Building, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Engineering Research Building, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".